PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.27%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
11.47%
Positive gross profit growth while 2127.T is negative. John Neff would see a clear operational edge over the competitor.
16.10%
Positive EBIT growth while 2127.T is negative. John Neff might see a substantial edge in operational management.
15.53%
Positive operating income growth while 2127.T is negative. John Neff might view this as a competitive edge in operations.
12.54%
Positive net income growth while 2127.T is negative. John Neff might see a big relative performance advantage.
12.53%
Positive EPS growth while 2127.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
12.53%
Positive diluted EPS growth while 2127.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
81.38%
10Y revenue/share CAGR 1.25-1.5x 2127.T's 58.85%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
81.38%
5Y revenue/share CAGR 1.25-1.5x 2127.T's 58.85%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
63.60%
3Y revenue/share CAGR at 75-90% of 2127.T's 76.92%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
95.12%
Net income/share CAGR 1.25-1.5x 2127.T's 70.80%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
95.12%
5Y net income/share CAGR 1.25-1.5x 2127.T's 70.80%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
58.16%
3Y net income/share CAGR 50-75% of 2127.T's 90.97%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
124.82%
10Y equity/share CAGR above 1.5x 2127.T's 82.44%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
124.82%
5Y equity/share CAGR above 1.5x 2127.T's 82.44%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
84.15%
3Y equity/share CAGR 1.25-1.5x 2127.T's 68.98%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-50.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-50.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
30.43%
Below 50% of 2127.T's 140.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
22462.50%
AR growth of 22462.50% while 2127.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
4.04%
Inventory shrinking or stable vs. 2127.T's 57.67%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
13.63%
Similar asset growth to 2127.T's 12.57%. Walter Schloss finds parallel expansions or investment rates.
5.35%
Similar to 2127.T's 5.46%. Walter Schloss finds parallel capital usage or profit distribution strategies.
141.03%
Debt growth of 141.03% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-26.00%
We cut SG&A while 2127.T invests at 20.12%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.